Single-use digital scope for kidney cancer surveillance
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a new, disposable flexible camera (ureteroscope) to safely check for or monitor upper urinary tract cancer in an office setting without putting you to sleep. The goal is to see if patients can tolerate this procedure comfortably while awake.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a history of upper tract urothelial carcinoma (a type of kidney or ureter cancer) that was treated with endoscopy, or you're suspected to have it based on imaging
- You are already scheduled for an office-based ureteroscopy procedure
- You do not have an active urinary tract infection
- You do not have ureteral strictures (scarring or narrowing of the ureter)
- You are able and willing to complete survey questions throughout the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a procedure done in the clinic, without general anesthesia, can safely check the upper urinary tract after kidney-sparing surgery for urothelial cancer. It may reduce the need for hospital visits.
This study is checking how well a flexible ureteroscope (a thin, flexible tube with a camera) finds any return of cancer in the upper urinary tract after surgery that saved the kidney. It may help detect problems early without needing more invasive tests.
This study uses a special ultrasound probe to measure how deep a cancer in the ureter or kidney pelvis has grown, which helps doctors choose the best treatment. It is for patients who are already planning surgery to remove the kidney and ureter.
This trial tests a new smart scope that automatically controls pressure and temperature during stone removal surgery. It aims to make the procedure safer for people who have a kidney stone and a urinary tract infection.
This study looks at how well patients do when they have kidney-sparing treatment (instead of complete kidney removal) for upper tract urothelial carcinoma. It helps doctors understand which patients can safely avoid losing their kidney.
This study checks tumor DNA found in blood and urine to see who is at higher risk of the cancer coming back after surgery. It may help doctors identify “minimal residual disease,” meaning tiny amounts of cancer that can remain after treatment.
Hear when a new Renal Pelvis and Ureter Urothelial Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.